The sixth Strategies for Engineered Negligible Senescence (SENS) Conference will be held from 3rd — 7th September 2013 at Queens College, Cambridge.

The conference program features 47 confirmed speakers so far, all of them world leaders in their field. As with previous conferences hosted by SENS Research Foundation, the emphasis of this meeting is on the design and implementation of rejuvenation biotechnologies — applications of regenerative medicine to age-related disease. Such biomedical interventions may jointly constitute a comprehensive panel of therapies that is sufficient to prevent or cure the diseases of aging, ensuring robust health for all.

In addition, there will be at least twenty short talks selected from submitted abstracts, as well as poster sessions each evening. Authors of short talks and posters will, like the invited speakers, be invited to submit a paper summarising their presentation for the proceedings volume, which will be published in the high-impact journal Rejuvenation Research early in 2014.

The purpose of the SENS conference series, like all the SENS initiatives, is to expedite the development of truly effective therapies to postpone and treat human aging by tackling it as an engineering problem: not seeking elusive and probably illusory magic bullets, but instead enumerating the accumulating molecular and cellular changes that eventually kill us and identifying ways to repair — to reverse — those changes, rather than merely to slow down their further accumulation. This broadly defined regenerative medicine – which includes the repair of living cells and extracellular material in situ —  applied to damage of aging, is what we refer to as rejuvenation biotechnologies.

The meeting will comprise invited talks, short oral presentations of submitted abstracts, and poster sessions. There will be no concurrent sessions. Talks will take place in the Fitzpatrick Lecture Hall. Poster sessions will take place each evening in the conservatory adjacent to the bar.